Unknown

Dataset Information

0

MUC1-C activates EZH2 expression and function in human cancer cells.


ABSTRACT: The EZH2 histone methyltransferase is a member of the polycomb repressive complex 2 (PRC2) that is highly expressed in diverse human cancers and is associated with a poor prognosis. MUC1-C is an oncoprotein that is similarly overexpressed in carcinomas and has been linked to epigenetic regulation. A role for MUC1-C in regulating EZH2 and histone methylation is not known. Here, we demonstrate that targeting MUC1-C in diverse human carcinoma cells downregulates EZH2 and other PRC2 components. MUC1-C activates (i) the EZH2 promoter through induction of the pRB?E2F pathway, and (ii) an NF-?B p65 driven enhancer in exon 1. We also show that MUC1-C binds directly to the EZH2 CXC region adjacent to the catalytic SET domain and associates with EZH2 on the CDH1 and BRCA1 promoters. In concert with these results, targeting MUC1-C downregulates EZH2 function as evidenced by (i) global and promoter-specific decreases in H3K27 trimethylation (H3K27me3), and (ii) activation of tumor suppressor genes, including BRCA1. These findings highlight a previously unreported role for MUC1-C in activating EZH2 expression and function in cancer cells.

SUBMITTER: Rajabi H 

PROVIDER: S-EPMC5547076 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

MUC1-C activates EZH2 expression and function in human cancer cells.

Rajabi Hasan H   Hiraki Masayuki M   Tagde Ashujit A   Alam Maroof M   Bouillez Audrey A   Christensen Camilla L CL   Samur Mehmet M   Wong Kwok-Kin KK   Kufe Donald D  

Scientific reports 20170807 1


The EZH2 histone methyltransferase is a member of the polycomb repressive complex 2 (PRC2) that is highly expressed in diverse human cancers and is associated with a poor prognosis. MUC1-C is an oncoprotein that is similarly overexpressed in carcinomas and has been linked to epigenetic regulation. A role for MUC1-C in regulating EZH2 and histone methylation is not known. Here, we demonstrate that targeting MUC1-C in diverse human carcinoma cells downregulates EZH2 and other PRC2 components. MUC1  ...[more]

Similar Datasets

| S-EPMC5436937 | biostudies-literature
| S-EPMC5908737 | biostudies-literature
| S-EPMC5078052 | biostudies-literature
| S-EPMC8026569 | biostudies-literature
| S-EPMC4916770 | biostudies-literature
| S-EPMC8321896 | biostudies-literature
| S-EPMC6881519 | biostudies-literature
| S-EPMC4530107 | biostudies-literature
| S-EPMC7778604 | biostudies-literature
| S-EPMC5260875 | biostudies-literature